A case of cutaneous leishmaniasis in a traveller from Belize, Central
America is reported. Leishmaniasis presents rarely in Australia and de
lays in diagnosis and treatment often occur. A high index of suspicion
in a patient who has returned from an endemic region is required, Sub
sequent confirmation of a diagnosis of cutaneous leishmaniasis is best
achieved by demonstration of the organism on skin biopsy, aspiration
or smear. The histology is variable and depends on geographic, parasit
e species and host factors. Speciation of New World disease as either
Leishmania braziliensis or Leishmania mexicana is important to determi
ne the risk of later development of mucosal disease, which normally on
ly occurs with L. braziliensis infection, and for optimal treatment. S
everal different modes of treatment have been suggested, but antimonia
ls, such as sodium stibogluconate, remain the treatment of choice in N
ew World cutaneous leishmaniasis.